Xiu Feng Li
Director/Board Member presso CHANGCHUN BCHT BIOTECHNOLOGY CO.
Patrimonio netto: 260 670 $ in data 31/03/2024
Profilo
Xiu Feng Li è vice direttore generale di Changchun High & New Technology Industries (Group), Inc. e fa parte del consiglio di amministrazione di altre 8 società. Il signor Li si è laureato all'Università di Jilin.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
21/04/2023 | 15 675 ( 0.58% ) | 260 670 $ | 31/03/2024 |
Posizioni attive di Xiu Feng Li
Società | Posizione | Inizio |
---|---|---|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Corporate Officer/Principal | 26/06/2018 |
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Director/Board Member | 01/03/2004 |
Changchun BCHT Pharmaceuticals Co. Ltd. | Director/Board Member | 20/08/2010 |
Changchun Chenguang Pharmaceutical Co. Ltd. | Director/Board Member | 20/08/2010 |
Jilin Maifeng Biological Pharmaceutical Co., Ltd. | Director/Board Member | 20/08/2010 |
Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | Director/Board Member | 20/08/2010 |
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Director/Board Member | 12/03/2014 |
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Director/Board Member | 18/03/2014 |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Director/Board Member | 01/08/2013 |
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Xiu Feng Li
Jilin University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
Aziende private | 8 |
---|---|
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Health Technology |
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
Changchun Chenguang Pharmaceutical Co. Ltd. | |
Changchun BCHT Pharmaceuticals Co. Ltd. | |
Jilin Maifeng Biological Pharmaceutical Co., Ltd. | |
Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |
Changchun Genescience Pharmaceuticals Co., Ltd.
Changchun Genescience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Genescience Pharmaceuticals Co., Ltd. is a private company that manufactures pharmaceutical products. Changchun Genescience Pharmaceuticals Co., Ltd. is based in Changchun, China. The Chinese company was founded in 1997. The CEO is Lei Jin. | Health Technology |
- Borsa valori
- Insiders
- Xiu Feng Li